It looks like he claimed there was a deal to make ozempic cost $150, but there isn't, at least not yet.
I have mixed feelings about the prices falling. Obviously I want more people to be able to afford these drugs. But without huge profit margins, it's not clear we'll get the same level of innovation we've come to expect. Yes, retatrutide and tirzepatide are awesome, but they cost billions to develop, and if we want more innovation like that, there needs to be billions more for the taking.
I think the best outcome would be that the government doesn't negotiate any such deal, Americans keep paying through the nose for few more years for peptides, and new entrants like Boehringer Ingelheim, Roche, and Viking add competitive pressure so the prices of sema, tirz, and eventually reta are forced down. Ozempic list won't fall to $150, but more PBMs/policies will cover it with reasonable copay.
Having said that, if Trump makes ozempic $150, Vance will be president through 2036.